8-K: Singular Genomics Faces Lawsuits Over Merger Disclosures, Voluntarily Supplements Proxy Statement

Singular Genomics Systems, Inc. is supplementing its proxy statement related to its merger with a Deerfield Management affiliate following lawsuits alleging misleading disclosures.

Summary

• Singular Genomics Systems, Inc. is facing lawsuits alleging that its proxy statement regarding the proposed merger with Singular Genomics Parent, LLC, omitted material information.
• The lawsuits, filed by purported stockholders, seek to enjoin the merger or obtain rescissory damages.
• Singular believes the claims are without merit but is voluntarily supplementing the proxy statement to avoid potential expense and delay.
• The supplemental disclosures relate to the engagement of TD Securities, standstill provisions in non-disclosure agreements, and the discounted cash flow analysis performed by Houlihan Lokey.
• The company has filed a definitive proxy statement with the SEC and urges security holders to read it carefully.
• The special meeting of Singular stockholders will be held virtually on February 19, 2025, to vote on the merger agreement.
• The supplemental disclosure includes an update to the financial projections table to include a 'Total Gross Profit' line item.
• The company clarifies that its Net Operating Losses (NOLs) are not considered a significant asset in connection with the merger due to limitations under Section 382 of the Internal Revenue Code.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the lawsuits and the need to supplement the proxy statement, although the company maintains that the claims are without merit. The discounted cash flow analysis may also raise concerns for some shareholders.

Positives

• Singular is proactively addressing concerns raised in the lawsuits by supplementing the proxy statement.
• The company believes the claims are without merit, suggesting confidence in the merger process.
• The supplemental disclosures provide additional information to stockholders, potentially increasing transparency.

Negatives

• The lawsuits could potentially delay or disrupt the merger process.
• The need to supplement the proxy statement suggests potential weaknesses in the initial disclosures.
• The discounted cash flow analysis indicated an implied value reference range of $12.05 to $29.14 per share, compared to the merger consideration of $20.00 per share, which may raise concerns for some shareholders.

Risks

• The merger may not be consummated in a timely manner, if at all.
• The failure to satisfy the conditions to the consummation of the merger, including the receipt of the requisite stockholder approval.
• The risk that the definitive merger agreement may be terminated in circumstances that require the company to pay a termination fee.
• Risks related to the diversion of management's attention from the company's ongoing business operations.
• Unanticipated difficulties or expenditures relating to the merger.
• The effect of the announcement of the merger on the company's business relationships, operating results, and business generally.
• Legal proceedings, judgments, or settlements related to the merger.

Future Outlook

The company provides forward-looking statements regarding the merger and its potential impact on the company's business and operations, but assumes no obligation to update these statements.

Management Comments

• Singular believes that the claims asserted in the Matters are without merit and that no supplemental disclosures are required under applicable law.
• The Special Committee, in its judgment, did not deem Singular's NOLs as material or a significant asset in connection with the Merger.

Industry Context

The document does not provide specific details on industry context beyond the company's own strategic evaluation process and the merger agreement. However, the mention of financial advisors and legal proceedings is typical in such transactions.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• The discounted cash flow analysis performed by Houlihan Lokey used a range of perpetuity growth rates ranging from 3.0% to 5.0% and discount rates ranging from 25.0% to 35.0%, which are standard practices in financial valuation.
• The document does not provide enough information to compare the company's financial projections to those of its competitors.

Legal Proceedings

• Two lawsuits were filed alleging that the Proxy Statement omitted material information that rendered it false or misleading.
• The Complaints generally allege that the Proxy Statement is misleading and omits and/or misrepresents certain purportedly material information in violation of applicable federal or state law.
• The Complaints seek, among other things: (i) to enjoin the consummation of the Merger; (ii) rescission or rescissory damages; (iii) an award of fees and expenses; and (iv) such other and further relief the court deems just and proper.

Stakeholder Impact

• Shareholders: The merger will result in Singular becoming a wholly owned subsidiary of Parent, and shareholders will receive $20.00 per share.
• Employees: The merger may have an impact on employees, although the specific details are not provided in this document.
• Customers: The merger may have an impact on customers, although the specific details are not provided in this document.

Next Steps

• The Special Meeting of Singular stockholders will be held on February 19, 2025, to vote on the Merger Agreement.
• The company will continue to defend against the lawsuits and provide updates as necessary.

Key Dates